Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 879

1.

Molecular identification of a cyclodextrin glycosyltransferase-producing microorganism and phylogenetic assessment of enzymatic activities.

Landriel SC, Castillo JDLM, Taboga OA, Ferrarotti SA, Gottlieb AM, Costa H.

An Acad Bras Cienc. 2019 Oct 7;91(3):e20180568. doi: 10.1590/0001-3765201920180568. eCollection 2019.

2.

Tildrakizumab Efficacy and Safety Are Not Altered by Metabolic Syndrome Status in Patients With Psoriasis: Post Hoc Analysis of 2 Phase 3 Randomized Controlled Studies (reSURFACE 1 and reSURFACE 2).

Lebwohl MG, Leonardi CL, Mehta NN, Gottlieb AB, Mendelsohn AM, Parno J, Rozzo SJ, Menter A.

J Am Acad Dermatol. 2019 Sep 26. pii: S0190-9622(19)32787-2. doi: 10.1016/j.jaad.2019.09.042. [Epub ahead of print] No abstract available.

3.

Achieving Consensus on Patient-Reported Outcome Measures in Clinical Practice for Inflammatory Skin Disorders: On Behalf of International Dermatology Outcome Measures and the American Academy of Dermatology.

Perez-Chada L, Taliercio VL, Gottlieb A, Van Beek M, Duffin KC, Reeder M, Merola JF, Swerlick RA.

J Am Acad Dermatol. 2019 Sep 13. pii: S0190-9622(19)32745-8. doi: 10.1016/j.jaad.2019.09.008. [Epub ahead of print]

PMID:
31525439
4.

Treatment of Medicare Patients with Moderate-to-Severe Psoriasis who Cannot Afford Biologics or Apremilast.

Natsis NE, Merola JF, Weinberg JM, Wu JJ, Orbai AM, Bagel J, Gottlieb AB.

Am J Clin Dermatol. 2019 Aug 26. doi: 10.1007/s40257-019-00468-0. [Epub ahead of print]

PMID:
31452091
5.

Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 Trial.

Helliwell PS, Deodhar A, Gottlieb AB, Boehncke WH, Xu XL, Xu S, Wang Y, Hsia EC, Gladman DD, Ritchlin CT.

Arthritis Care Res (Hoboken). 2019 Aug 17. doi: 10.1002/acr.24046. [Epub ahead of print]

PMID:
31421033
6.

Clinical considerations for the management of psoriasis in women.

Gottlieb AB, Ryan C, Murase JE.

Int J Womens Dermatol. 2019 Apr 10;5(3):141-150. doi: 10.1016/j.ijwd.2019.04.021. eCollection 2019 Jul. Review.

7.

Marriage, Cohabitation, and Crime: Differentiating associations by partnership stage.

Gottlieb A, Sugie NF.

Justice Q. 2019;36(3):503-531. doi: 10.1080/07418825.2018.1445275. Epub 2018 Apr 11.

PMID:
31359908
8.

The Effect of Direct and Vicarious Police Contact on the Educational Achievement of Urban Teens.

Gottlieb A, Wilson R.

Child Youth Serv Rev. 2019 Aug;103:190-199. doi: 10.1016/j.childyouth.2019.06.009. Epub 2019 Jun 10.

PMID:
31359898
9.

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.

Elmets CA, Lim HW, Stoff B, Connor C, Cordoro KM, Lebwohl M, Armstrong AW, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Leonardi CL, Lichten J, Mehta NN, Paller AS, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A.

J Am Acad Dermatol. 2019 Sep;81(3):775-804. doi: 10.1016/j.jaad.2019.04.042. Epub 2019 Jul 25.

PMID:
31351884
10.

Cutaneous and systemic IgG4-related disease: a review for dermatologists.

Shenoy A, Mohandas N, Gottlieb A.

Dermatol Online J. 2019 Jun 15;25(6). pii: 13030/qt9w91m8dz.

11.

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Perreault L, Pan Q, Schroeder EB, Kalyani RR, Bray GA, Dagogo-Jack S, White NH, Goldberg RB, Kahn SE, Knowler WC, Mathioudakis N, Dabelea D; Diabetes Prevention Program Research Group.

Diabetes Care. 2019 Sep;42(9):1809-1815. doi: 10.2337/dc19-0244. Epub 2019 Jul 18.

PMID:
31320445
12.

Implications of Immunotherapy in Hepatobiliary Tumors.

Gottlieb A, Best J, Canbay A.

Visc Med. 2019 Mar;35(1):18-26. doi: 10.1159/000496755. Epub 2019 Feb 8. Review.

PMID:
31312646
13.

Sustained Efficacy of Secukinumab in Subjects with Moderate-to-Severe Palmoplantar Psoriasis: 2·5-Year Results from GESTURE, a Randomized, Double-blind, Placebo-controlled Trial.

Gottlieb AB, Kubanov A, van Doorn M, Sullivan J, Papp KA, You R, Regnault P, Frueh JA.

Br J Dermatol. 2019 Jul 8. doi: 10.1111/bjd.18331. [Epub ahead of print]

PMID:
31286480
14.

Identification of clinically related requirements of a novel assistive device for people with a high spinal cord injury.

Gottlieb A, Plotnik M, Kizony R, Katsarou Z, Bostantjopoulou S, Zeilig G.

PLoS One. 2019 Jun 28;14(6):e0218393. doi: 10.1371/journal.pone.0218393. eCollection 2019.

15.

Measuring Psoriatic Arthritis Symptoms, A Core Domain in Psoriasis Clinical Trials.

Perez-Chada LM, Gottlieb AB, Cohen J, Mease P, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF.

J Am Acad Dermatol. 2019 Jun 1. pii: S0190-9622(19)30879-5. doi: 10.1016/j.jaad.2019.05.075. [Epub ahead of print]

PMID:
31163240
16.

Report of the Skin Research Workgroups from the GRAPPA 2018 Annual Meeting.

Perez-Chada LM, Merola JF, Armstrong AW, Gottlieb AB.

J Rheumatol Suppl. 2019 Jun;95:28-32. doi: 10.3899/jrheum.190124.

PMID:
31154401
17.

Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Callis Duffin K, Gladman DD, Gottlieb AB, Goel N.

J Rheumatol Suppl. 2019 Jun;95:1-3. doi: 10.3899/jrheum.190112.

PMID:
31154397
18.
19.

The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies.

Kavanaugh A, Gottlieb A, Morita A, Merola JF, Lin CY, Birt J, Shuler CL, Hufford MM, Thaçi D.

Ann Rheum Dis. 2019 Sep;78(9):1215-1219. doi: 10.1136/annrheumdis-2018-215003. Epub 2019 May 21.

20.

Probiotics for oral and vulvovaginal candidiasis: A review.

Shenoy A, Gottlieb A.

Dermatol Ther. 2019 Jul;32(4):e12970. doi: 10.1111/dth.12970. Epub 2019 May 30. Review.

PMID:
31112355

Supplemental Content

Loading ...
Support Center